Since lower expression of CCR5 increased the risk of severe COVID-19, as estimated from the Mendelian randomization analyses, the significant difference in GDE-score indicates that carriers of the introgressed segment would have increased predisposition to severe COVID-19. Here, CCR5 is linked to COVID-19.